Our findings that silencing of TRPV4 suppressed the AKT-mTOR pathway prompted us to investigate whether PTEN, a highly effective tumor suppressor, through negative regulation of the PI3K/AKT/mTOR pathway51, is involved in this process. The gene discussed is AKT1; the disease is neoplasm.